Company · CIK 0001106838
Sonnet BioTherapeutics Holdings, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 10-K/ASonnet BioTherapeutics Holdings, Inc.0001493152-26-033712 · 447.9 KBSEC(opens sec.gov)
- 10-KAnnual report0001493152-25-027978 · 9.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001493152-25-025884 · 2.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001493152-25-025677 · 247.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-25-024006 · 246.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001493152-25-015994 · 217.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0001641172-25-023468 · 5.2 MBSEC(opens sec.gov)
- 8-KCurrent report0001641172-25-021927 · 279.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001641172-25-021007 · 204.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001641172-25-020237 · 202.3 KBSEC(opens sec.gov)
Insiders
- ADAMS RICHARDPresident. ARB *
- Bhatt NaileshDirector
- Carroll J MichaelDirector
- Cini John K.Director
- Cross John Harry IIIChief Financial Officer
- Dexter SusanDirector
- Dyrness Albert D.Director
- ENGLANDER ISRAEL AMay be deemed a group member.
- Glick Frederick LPresident
- Griffith Donald J.Director, Chief Financial Officer
Tickers
No tickers on record.
Addresses
business
100 OVERLOOK CENTER SUITE 102
PRINCETON, NJ, 08540
mailing
100 OVERLOOK CENTER SUITE 102
PRINCETON, NJ, 08540
Former names
- Chanticleer Holdings, Inc.2020-03-31
- TULVINE SYSTEMS INC2005-03-31
Same industry